Provided By GlobeNewswire
Last update: Aug 22, 2024
REGINA, Saskatchewan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has agreed to acquire from two arm’s length vendors (the “Vendors”) a 90% interest in a pharmacy (the “Acquired Pharmacy”) located in Western Canada. The aggregate purchase price for the 90% interest is $2,207,170, will be funded from cash and is expected to close on or about August 30, 2024, subject to satisfaction of customary closing conditions.